Cite

    Aviad Zick et al.. “Treatment inferred from mutations identified using massive parallel sequencing leads to clinical benefit in some heavily pretreated cancer patients.” Medicine, vol. 96, no. 20, 2017, p. . http://access.bl.uk/ark:/81055/vdc_100046676473.0x000010